Gilead’s Kite Hopes To Reinforce Commercial CAR-T Lead With Yescarta Data

 
• By Alaric DeArment
  
Gilead and Kite at ASCO 2023 • Source: Alaric DeArment
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences